iothalamic acid has been researched along with Cystic Fibrosis of Pancreas in 3 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the pharmacokinetics of ciprofloxacin in 12 adult males with and 12 adult males without cystic fibrosis (CF)." | 9.06 | Pharmacokinetics of ciprofloxacin in cystic fibrosis. ( Davis, RL; Heggen, L; Koup, JR; Smith, AL; Stempel, D; Weber, A; Williams-Warren, J, 1987) |
| " Eight cystic fibrosis patients and 8 healthy volunteers were recruited into a crossover pharmacokinetic study in which participants received 180 mg fexofenadine with or without 1 g probenecid twice a day." | 6.73 | Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. ( Beringer, PM; Burckart, GJ; Hidayat, L; Liu, S; Louie, S; Rao, AP; Shapiro, B, 2008) |
| "We studied the pharmacokinetics of ciprofloxacin in 12 adult males with and 12 adult males without cystic fibrosis (CF)." | 5.06 | Pharmacokinetics of ciprofloxacin in cystic fibrosis. ( Davis, RL; Heggen, L; Koup, JR; Smith, AL; Stempel, D; Weber, A; Williams-Warren, J, 1987) |
| " Eight cystic fibrosis patients and 8 healthy volunteers were recruited into a crossover pharmacokinetic study in which participants received 180 mg fexofenadine with or without 1 g probenecid twice a day." | 2.73 | Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. ( Beringer, PM; Burckart, GJ; Hidayat, L; Liu, S; Louie, S; Rao, AP; Shapiro, B, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Beringer, PM | 2 |
| Hidayat, L | 2 |
| Rao, AP | 2 |
| Louie, S | 1 |
| Burckart, GJ | 1 |
| Shapiro, B | 1 |
| Heed, A | 1 |
| Zheng, L | 1 |
| Owens, H | 1 |
| Benitez, D | 1 |
| Davis, RL | 1 |
| Koup, JR | 1 |
| Williams-Warren, J | 1 |
| Weber, A | 1 |
| Heggen, L | 1 |
| Stempel, D | 1 |
| Smith, AL | 1 |
3 trials available for iothalamic acid and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, | 2008 |
GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis.
Topics: Biomarkers; Creatinine; Cystatin C; Cystic Fibrosis; Female; Glomerular Filtration Rate; Humans; Iot | 2009 |
Pharmacokinetics of ciprofloxacin in cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic | 1987 |